Order Article Reprints

Furer V, Eviatar T, Zisman D, Peleg H, Braun-Moscovici Y, Balbir-Gurman A, Paran D, Levartovsky D, Zisapel M, Elalouf O, et al. Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab. Vaccines. 2022; 10(6):901. https://doi.org/10.3390/vaccines10060901

Furer, Victoria, Tali Eviatar, Devy Zisman, Hagit Peleg, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Daphna Paran, David Levartovsky, Michael Zisapel, Ofir Elalouf, and et al. 2022. "Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab" Vaccines 10, no. 6: 901. https://doi.org/10.3390/vaccines10060901

Furer, V., Eviatar, T., Zisman, D., Peleg, H., Braun-Moscovici, Y., Balbir-Gurman, A., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Broyde, A., Polachek, A., Feld, J., Haddad, A., Gazitt, T., Elias, M., Higazi, N., Kharouf, F., ... Elkayam, O. (2022). Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab. Vaccines, 10(6), 901. https://doi.org/10.3390/vaccines10060901